Atsidolak
Producer: Polpharma/Medana Pharma S. A. (Polfarm / Medan of Pharm S.A.) Poland
Code of automatic telephone exchange: A07FA10
Release form: Firm dosage forms. Powder for oral solution.
General characteristics. Structure:
Active agent: maltodextrin, the lyophilized lactobacilli of Lactobacillus rhamnosus GG, a fruktooligosakharida (FOS), silicon dioxide.
Pharmacological properties:
Atsidolak promotes increase in immune stability of an organism. It can be recommended for intestinal microflora normalization, in particular in time and after use of antibiotics.
Indications to use:
— prevention and treatment of a disbioz of intestines;
- diarrhea against the background of reception of antibiotics;
- allergy to foodstuff.
Route of administration and doses:
Atsidolak
Children aged from 1 up to 3 years — on 1 sachet a day. To dissolve contents of a sachet in not less than 100 ml of liquid.
Children aged from Z years and adults — on 1–2 sachets a day. Previously to dissolve sachet contents in water, milk or yogurt, to use right after preparation.
Use duration: during antibiotic treatment, and also during 2–3 weeks after its end. Further to coordinate the term of the use with the doctor.
Features of use:
Atsidolak. It is not necessary to exceed a daily dose.
Side effects:
At use of drug in the recommended doses of side effects it was not revealed. At hypersensitivity to components of drug allergic reactions are possible.
Interaction with other medicines:
Are not known.
Contraindications:
Intolerance of components of a product.
Overdose:
Data are absent. In case of reception of a dose which is higher than recommended it is necessary to wash out a stomach, to accept enterosorbents (absorbent carbon), to carry out a symptomatic treatment.
Storage conditions:
Atsidolak — in the dry place at a temperature not above 25 °C.
Issue conditions:
Without recipe
Packaging:
ATSIDOLAK
time. for оральн. solution of a sachet of 3 g, No. 10.